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 ABSTRACT 
While the prevalence of osteoporosis and risk factors for low bone mineral density 
(BMD) has been well documented in Caucasian populations, there is a lack of data from 
Asia. This work was designed to clarify to what extent osteoporosis could be regarded as 
a major public health problem in Vietnam. Furthermore, to elucidate the prevalence of 
certain risk factors, such as vitamin D deficiency and other determinants of bone mass as 
a basis to indentify high-risk individuals among the Vietnamese women and men.  
The clinical studies were designed as cross-sectional investigations using a multistage 
sampling scheme. Within the setting of northern Vietnam (latitude 21o
Reference values for peak BMD were defined. These data allowed the calculation of T-
scores and thus for the first time, an accurate identification of osteoporosis in a 
Vietnamese population. As determined at the femoral neck, the prevalence of 
osteoporosis was 17-23% in women and 9% in men. The results clearly suggest that 
osteoporosis is an important public health problem. Postmenopausal women living in 
urban areas experienced osteoporosis more than rural residents. Serum levels of 
25(OH)D and estrogen were significantly associated with bone mass in both women and 
men. The prevalence of vitamin D deficiency (<20 ng/mL) was very high, 30% in 
women and 16% in men.   
N), districts were 
selected to represent urban and rural areas. In total 612 healthy women and 222 men 
aged 13-83 years were investigated. BMD was measured at the lumbar spine, femoral 
neck and total hip in all qualified subjects with dual energy X-ray absortiometry. Serum 
concentrations of 25(OH)D, parathyroid hormone, estrogen and testosterone were 
quantified by electrochemiluminescence immunoassay. Data on clinical history and 
lifestyle were collected by individual face-to-face interviews. 
An experimental study on the isoflavone content of different soymilk preparations was 
performed by HPLC (high pressure liquid chromatography). Values of isoflavones were 
very low, around 60-80 mg/L, and there were only 10-20% of bioactive aglycones. This 
is far below the reported threshold levels to exert significant effects on bone.  
In the future these data will be useful as a valuable reference base to diagnose 
osteoporosis and for the clinical management of its consequences. The high prevalence 
of vitamin D deficiency should raise the awareness of potentially important health issues 
such as osteoporosis but also about other serious diseases within the Vietnamese society.  
Key words: Vietnamese men and women, peak bone mineral density, osteoporosis, 
vitamin D deficiency, estrogen, testosterone, soymilk, aglycone content. 
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1 BACKGROUND 
1.1 OSTEOPOROSIS 
 Osteoporosis, and fracture as its consequence, is recognized as an 
important global public health problem. Fracture is associated with increased mortality 
(Center et al 1999), concomitant morbidity, and reduced quality of life (Randell et al 
2000).  In the year of 2000 alone, there were an estimated 9 million osteoporotic 
fractures worldwide, resulting in a loss of 5.8 million disability-adjusted life-years 
(Johnell & Kanis 2006). It is projected that approximately half of all hip fractures in the 
world occur in Asia (Cooper et al 1992; Lau et al 2001). Despite the expected magnitude 
of the problem, the prevalence of and risk factors for osteoporosis in Asian countries are 
not well documented due to lack of epidemiologic data.  
 Osteoporosis is generally thought as a “woman’s disease” because the 
prevalence of osteoporosis and the rate of fractures are much higher in postmenopausal 
women than in older men (National Osteoporosis Foundation, 2002). However, older 
men still suffer from poor health outcomes related to osteoporosis and fractures. Aging 
men lose bone mineral density (BMD) at a rate of approximately 1% per year (Hannan 
et al 2000). It is estimated that one in five men over the age of 50 will suffer from an 
osteoporotic fracture during his lifetime (Melton et al 1992). Additionally, a lower 
proportion of men at high risk of fracture are treated than women at high risk (Kiebzak et 
al 2002). Among many different sites of osteoporotic fracture, the hip fracture 
contributes to the greatest morbidity and mortality (Johnell & Kanis 2006). Men also 
tend to have worse outcomes after fracture than women; they are twice as likely to die 
after a hip fracture than women (Haentjens et al 2010). Thus, it is important to pay 
attention not only to women but also to men as regards osteoporosis, its diagnosis, 
prevention and treatment. 
 Because bone loss occurs insidiously and is initially asymptomatic, 
osteoporosis is often diagnosed only after the first clinical fracture has occurred (Fig 1) 
(Unnanuntana et al 2010; Vestergaard et al 2005). Osteoporosis and fracture are 
preventable if we could have early diagnosis or indentify the high-risk factors and 
individuals. 
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(a) 
 
(b) 
(c)  
  
Figure 1. Osteoporosis at a glance 
Osteoporosis is often 
asymptomatic. A decrease 
in height may be the only 
first sign of the disease. 
 
 
 
 
 
 
 
 
 
A gradual loss of 
trabecular bone may cause 
a vertebral crush fracture. 
 
 
 
 
 
 
 
 
 
 
A hip fracture may occur 
after only a minor trauma.  
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1.2 BONE MINERAL DENSITY 
 Osteoporosis is a disease characterized by a systemic skeletal impairment 
of bone mass and micro-architecture that lead to an increase in bone fragility and 
susceptibility to fracture (2001).  
 At present, the best method for screening and diagnosis of osteoporosis in 
both men and women is measurement of bone mineral density by dual-energy xray 
absorptiometry (DXA). The bone mineral content is given as gram within the area 
measured (g/cm2
 
). For the diagnosis of osteoporosis, the BMD of an individual is 
compared to the mean value of a young population (peak bone mass). A T-score value is 
calculated from an individual’s areal BMD levels and reference values. The T-score is 
the number of standard deviations (SDs) for an individual’s BMD from the mean of the 
young reference group (Baim et al 2008). A person is diagnosed with osteoporosis if the 
T-score is -2.5 or lower, or osteopenia/low bone mass if the T-score is between -2.5 and 
-1.0; or normal if the T-score is -1.0 or higher. A low BMD is the most important risk 
factor of fracture. A decrease of 1 SD will increase the risk of fracture about 2-3 fold 
(Kung et al 2007b) (Fig 2). Therefore, it is essential to obtain accurate BMD data 
measured by DXA. 
 The World Health Organization recommends the femoral neck as the most 
important anatomic region for the diagnosis of osteoporosis. However, the International 
Society of Clinical Densitometry (ISCD) and the National Osteoporosis Foundation 
(NOF) guidelines recommend that a diagnosis of osteoporosis should be based on three 
sites i.e. the femoral neck, the total hip and the lumbar spine. Measurement on these 
different sites could come up with different results.   
 
 The ISCD recommends that a young female reference group should be 
used to calculate the T-score for both men and women (Baim et al 2008). However, the 
NOF suggests that a young reference group value of the same sex should be used to 
diagnose osteoporosis (NOF, 2010). Women have lower levels of BMD than men (NOF, 
2010); and BMD is influenced by genetic and environmental factors (Krall & Dawson-
Hughes 1993). Therefore, it should be important to have ethnic- and sex-specific 
reference values in order to obtain accurate diagnosis.  
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Figure 2. Ten-year risk of osteoporotic fracture in southern Chinese women 
according to age and BMD T-score (Kung et al 2007b). Reproduced with the 
permission from the publisher. 
 
1.3 LIFE STYLE FACTORS AND DETERMINANTS OF BONE MASS 
1.3.1 Bone biology  
 Bone is composed of support cells (osteoblasts and osteocytes), 
remodeling cells (osteoclasts), osteoid (non-mineral matrix of collagen and 
glycosaminoglycans) and inorganic mineral salts (hydroxyapatite, a complex of calcium 
and phosphate). Osteoblasts are responsible for synthesis of the osteoid and its 
mineralization, which makes bone rigid and hard. Resorption of mineralized bone is 
done by osteoclasts.  
 Bone remodeling is the coupled process of bone formation and bone 
resorption to maintain bone mass in adults (Fig. 3). This process consists of five phases. 
In the activation phase the resting bone surface becomes a remodeling surface. 
Precursors of osteoclasts differentiate into functional osteoclasts due to stimulation by 
cytokines and growth factors. In the next phase (resorption phase), osteoclasts digest 
mineralized bone, making scalloped erosions in the bone surface. After the resorption 
phase there is a reversal phase, coupling formation to resorption. This requires 
proliferation and differentiation of osteoblasts precursor cells and accumulation of the 
new osteoblasts in the resorption cavity. This phase is followed by the synthesis of 
osteoid and its subsequent mineralization (formation phase) by osteoblasts. Finally, most 
% 
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of the osteoblasts become inactive bone lining cells on the bone surface (quiescence 
phase). Some osteoblasts however become incorporated in the mineralized bone. These 
cells, then called osteocytes, are thought to communicate with the osteoblasts and to 
initiate the next cycle of bone resorption and formation (Parfitt 1984). 
 
 
 
Figure 3. Five phases of bone remodeling 
  
1.3.2 Sex steroid hormones and bone 
 Sex steroids i.e. estrogen and testosterone are major determinants of bone 
metabolism in both women and men (Kuchuk et al 2007). In vitro and in vivo studies 
indicate estrogens and androgens to act via different cellular mechanisms (Clarke & 
Khosla 2009).  
 The bone sparing effect of estrogen is anti-resorption by inhibition of 
osteoclast activity. The cellular and molecular mechanism by which estrogen 
deficiency leads to bone loss are increasingly well understood (Fig 4). Estrogen 
deficiency increases receptor activation of nuclear factor kappa B ligand (RANKL), 
(1) Activation phase 
 
(2) Resorption phase 
 
 
 
(3) Reversal phase 
 
 
 
(4) Formation phase 
 
 
 
(5) Quiescence phase 
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leading to increased osteoclast recruitment and activation and decreased osteoclast 
apoptosis. RANKL is the final key molecule required for osteoclast development and 
is normally expressed by bone marrow stromal/osteoblast precursor cells, T and B 
lymphocytes. RANKL binds to its receptor RANK on osteoclast lineage cells and is 
neutralized in the bone microenvironment by its soluble decoy receptor 
osteoprotegerin (OPG), which is produced and secreted by osteoblast lineage cells.  
 Combined in vitro and in vivo studies have shown that estrogen normally 
suppresses RANKL production by osteoblastic cells and T and B lymphocytes and 
increases OPG production by osteoblastic cells. Thus, estrogen deficiency leads to an 
alteration in the RANKL/OPG ratio that favors bone resorption (Clarke & Khosla 
2010). 
  Estrogen normally also increases the production of transforming growth 
factor (TGF)-β by osteoblast precursor cells. TGF-β induces apoptosis of osteoclasts. 
Estrogen also directly stimulates apoptosis of osteoclast precursor cells and decreases 
osteoclast precursor differentiation by blocking RANKL/macrophase-colony 
stimulating factor (M-CSF)-induced activator protein-1-dependent transcription by 
reducing c-jun activity. C-jun activity is reduced by decreasing c-jun transcription and 
decreasing phosphorylation. Estrogen is also capable of inhibiting the activity of 
mature osteoclasts by direct, receptor-mediated mechanisms (Clarke & Khosla 2010). 
 
 
Figure 4. Summary of stimulatory and inhibitory factors involved in osteoclast 
development and apoptosis. (Reproduced from Quinn & Saleh 2009 with 
permission).  
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 The skeletal effect of androgens may be partly mediated from local 
aromatization to estrogen. However, there are also data to support a direct androgen 
action on bone. The presence of specific androgen receptors in cultured osteoblasts has 
been reported (Huber et al 2001). Androgens were shown to stimulate proliferation and 
differentiation of osteoblasts and to inhibit apoptosis. In animal studies, treatment with 
dihydrotestosterone which cannot be aromatized to estrogen, stimulated bone formation 
and thus supported a direct stimulatory effect of androgens on bone (Vanderschueren et 
al 2004). 
 In women, reduced estrogen levels e.g. following oophorectomy or natural 
menopause are well-known to increase bone loss, increase the risk of osteoporosis and 
fracture (Clarke & Khosla 2010; Riggs et al 2002). Oophorectomy also leads to a decline 
in testosterone levels by one-half, whereas the levels in postmenopausal women with 
intact ovaries are variable (Hughes et al 1991). Bone resorption increases by 90% after 
menopause, whereas bone formation also increases but only by 45%, as assessed by 
markers of bone formation (Garnero et al 1996). This difference favors greater bone 
resorption, which leads to accelerated bone loss during the first 8-10 years after 
menopause. Increased bone resorption leads to an efflux of calcium from the skeleton 
into the extracellular pool. Compensatory increased renal calcium excretion (Young & 
Nordin 1967), decreased intestinal calcium absorption (Gennari et al 1990), and partially 
suppressed parathyroid hormone (PTH) secretion (Riggs et al 1998) prevent 
development of hypercalcemia.  
 In men, the relation between sex hormone levels, bone loss and risk of 
osteoporosis is more uncertain. Also, the relative importance of testosterone versus 
estrogen for the maintenance of BMD in men is unclear. Men with gonadal insufficiency 
have lower BMD than healthy subjects of the same age and testosterone replacement 
therapy has been suggested to reverse this condition (Khosla 2006). However, the role of 
testosterone for BMD in men has also been questioned (Clarke & Khosla 2009; Khosla 
et al 2001). 
 Risk factors for low BMD and for osteoporosis in Asian populations have 
not been well documented, particularly with respect to men. Genetic variations between 
Asian and Caucasian populations in sex steroid hormone metabolism regulating bone 
mass have been demonstrated (Jakobsson et al 2006). Furthermore, there may be 
ethnical differences in gene polymorphisms involved in bone metabolism (Gorai et al 
2007).   
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For decades now, hormone replacement therapy (HRT) has been employed to relieve 
menopausal symptoms such as hot flashing, sweating and sleep disturbances, as well as 
for prevention of osteoporosis and related bone fractures in women. However, more 
recent randomized as well as epidemiological investigations have revealed that HRT of 
postmenopausal women with estrogen and progestin increases the risk for breast cancer 
and thrombosis (Santen et al 2010). Consequently, the benefits versus risks of such 
treatment have been discussed extensively and new guideline proposed (Santen et al 
2010). Although the use of HRT has never been widespread in Vietnamese 
postmenopausal women, alternative therapy for treatment and prevention of osteoporosis 
and fracture is strongly needed. 
 
1.3.3 Phytoestrogens and bone 
 Currently there is a growing interest in plant-derived phytoestrogens which 
may offer a cheap and non-pharmacological alternative for the prevention and treatment 
of bone loss in postmenopausal women (Albertazzi & Purdie 2002). It is often assumed 
that Asian populations have a lower rate of osteoporosis because of a high phytoestrogen 
content in their traditional diet (Adlercreutz & Mazur 1997; Eden 1998).  Soy bean 
based food is an important source of plant protein in Asia including Vietnam. It has been 
estimated that between 200-300 thousand tons of local soy bean are consumed every 
year in different soy based products e.g. soymilk, tofu and soy sauce (Huong 2004). 
While soymilk and tofu are consumed daily by most Vietnamese individuals, the 
prevalence of osteoporosis in Vietnam is nevertheless still high and comparable to that 
of many Western populations (I).   
 Bisphosphonates and selective estrogen receptor modulators (SERMs) e.g. 
raloxifene or tamoxifen offer alternative treatments. However, these drugs are relatively 
expensive and their affordability in developing countries, where 1.5 billion elderly (60 
years and more) are estimated to be living by 2050 (Mirkin 2001), is limited. 
   The most important biologically active phytoestrogens (aglycones) 
recognized are daidzein, glycitein and genistein and their inactive isomers (glycosides) 
daidzin, glycitin and genistin (Cassidy et al 2006; Song et al 1998). The chemical 
structure of these isoflavones is similar to that of estrogen (Fig 5). They have a higher 
affinity to estrogen receptor (ER) beta (Kuiper et al 1997) than ER alpha (Makela et al 
1999). 
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Figure 5. Chemical structures of the most common phytoestrogens found in plants 
(top and middle) compared with estradiol (bottom). 
 
 While many scientific panels have now reached a consensus on the effect 
of phytoestrogens on cardiovascular disease prevention (Erdman 2000; J.H.C.I 2002; 
U.S 1999), the same conclusions have not been reached for prevention and treatment of 
osteoporosis (Branca 2003; Weaver & Cheong 2005). 
 The effectiveness of soy isoflavones on bone metabolism in 
postmenopausal women is controversial. In a recent meta-analysis from 9 randomized 
clinical trials, significant inhibition of bone resorption and stimulation of bone formation 
were observed (Ma et al 2008b). In contrast, Cheong et al. found no significant effects of 
isoflavone treatment (Cheong et al 2007). 
 The minimal threshold intake of dietary phytoestrogen to yield significant 
effects on bone has been suggested to be between 90 and 120 mg/day of aglycones (Ma 
et al 2008a; Wong et al 2009). Soymilk in general seems to provide a better 
pharmacokinetic profile of isoflavones than more solid matrix consumables, because its 
absorption is rapid with easily achievable high peak concentrations (Cassidy et al 2006). 
Previous studies found marked differences in isoflavone content among different 
commercially available soy foods in Australia and in the US (Setchell & Cole 2003). 
Therefore, it is important to quantify the isoflavone content in different commercial soy 
products. 
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1.3.4 Vitamin D and bone 
 Vitamin D is the name of a group of fat-soluble compounds that are 
essential for maintaining the appropriate mineral balance in the body. The most 
important forms of vitamin D are D2 (ergocalciferol) and D3 (cholecalciferol) (Fig 6). 
These two forms differ chemically only in their side-chain structure, vitamin D2
 Vitamin D
 has a 
side chain that contains a double bond between carbon 22 and 23 and a carbon 24 methyl 
group.  
3 is produced from 7-dehydrocholesterol in the skin as a result 
of ultraviolet (UV) irradiation or by digestion of animal products. Vitamin  D2 is formed 
by UV radiation from the plant sterol ergosterol and humans can obtain vitamin D2 only 
from plant products. Calciferol-vitamin D refers to both vitamin D2 and D3
   
. Vitamin D 
is biologically inactive and requires metabolism in the liver on carbon 25 to form the 
main circulating form of vitamin D, 25-hydroxychole-calciferol or calcidiol [25(OH)D]. 
The compound 25(OH)D is used to measure vitamin D status. To be activated, 25(OH)D 
must be converted into 1,25-dihydroxychole-calciferol or calcitriol [1,25(OH)D] (Fig 6). 
Vitamin D-biding protein (VDBP) is the major carrier of vitamin D and its metabolites, 
25(OH)D and 1,25(OH)D. The vitamin D receptor (VDR) is the mediator of the 
biological actions of 1,25(OH)D. Receptor polymorphisms, hormonal status and several 
other factors influence the possible effects of vitamin D (Holick & Chen 2008). 
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Figure 6. Schematic representation of the synthesis and metabolism of vitamin D 
for regulating calcium, phosphorus and bone metabolism. (During exposure to 
sunlight, 7-dehydrocholesterol (7-DHC) in the skin is converted to pre-vitamin D3 and 
then by a heat-dependent process to vitamin D3. Vitamin D made in the skin or ingested 
from the diet is converted by the vitamin D-25-hydroxylase to [1,25(OH)2D]. This will 
increase the 25-hydroxyvitamin D-24-hydroxylase to catabolize 1,25(OH)2D and 
25(OH)D into the water-soluble biologically inactive calcitroic acid.  1,25(OH)2D will 
enhance intestinal calcium absorption and it is recognized by its receptor in osteoblasts. 
After ligand binding, there is an increase in the expression of the activator NFK
   
B 
(RANKL).  
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 Vitamin D plays an important role in the regulation of calcium and bone 
metabolism (Bischoff-Ferrari; Lips 2006; Mason et al). Lack of 25(OH)D is a cause of 
rickets due to abnormality in bone remodeling. Supplementation of 25(OH)D will 
reverse the abnormal bone formation (Holick & Chen 2008). Recent studies have also 
demonstrated the presence of specific receptors in a wide variety of tissues (Haussler et 
al; Holick 2008; Mason et al), and indicated many important effects of vitamin D besides 
bone health (Bischoff-Ferrari; Holick 2008; Mason et al).  
 Indeed, vitamin D deficiency has been associated with certain forms of 
cancer (Ahearn et al; Holick 2004; 2008; Norton & O'Connell), type II diabetes, 
cardiovascular disorders (Forman et al 2007; Giovannucci et al 2008; Lee et al 2008; 
Witham et al), autoimmune and infectious diseases (Cutolo & Otsa 2008; Liu et al 2006; 
Martineau et al; Munger et al 2004). A recent meta-analysis found a marked increase in 
the risk of mortality among vitamin D deficient individuals as compared to those with 
normal 25(OH)D levels (Zittermann et al).  
 Although there is no consensus on a definition of vitamin D deficiency, it 
has been generally agreed that measurement of 25(OH)D should be used as an indicator 
of an individual’s vitamin D status (Holick & Chen 2008; Lips).  Serum 25(OH)D levels 
below 20 ng/mL are considered to be “deficiency” (Sai et al 2011). Using this criterion, 
studies on vitamin D status in different populations have shown considerable variation in 
the prevalence of vitamin D deficiency (Mithal et al 2009).  The common trend in all 
studies is that populations in temperate regions have higher prevalence of vitamin D 
deficiency than populations in tropical regions (Lips; Mithal et al 2009), which indicates 
an effect of sunlight exposure on vitamin D variation (Fig 7).   
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Figure 7. World map of geographic regions to skin ability to synthesize vitamin 
D. Developed countries are shown in white. Information on the prevalence of 
hypovitaminosis D, risk factors and effect on health was available from 23 
developing countries that are indicated as shaded areas on the map. Reproduced with 
permission from (Tavera-Mendoza & White 2007). 
 
 Approximately 90% of vitamin D is synthesized in the skin after sunlight 
exposure (Holick 2006; Holick & Chen 2008). A small amount of vitamin D can be 
absorbed through food intake (Holick 2007). It is therefore assumed that people living in 
countries with high amounts of sunlight may have a lower risk of vitamin D deficiency. 
However, recent studies in tropical countries have indicated that the prevalence of 
vitamin D deficiency still could be as high as that observed in Western populations 
(Mithal et al 2009). Melanin is extremely efficient in absorbing UVB radiation and thus, 
increased skin pigmentation markedly reduces vitamin D synthesis (Clemens et al 1982; 
Holick & Chen 2008; Springbett et al). Reports from Hong Kong (Wat et al 2007), 
Malaysia and Singapore (Hawkins 2009) have indicated that between 60% and 100% of 
the population had vitamin D levels below 30 ng/mL, a level that is considered 
“insufficient”. However, these studies were conducted on urban residents who may have 
a lower level of sunlight exposure than rural residents. Moreover, 25(OH)D production 
is known to be affected by seasonal variation (Karohl et al; Snellman et al 2009) which 
was not taken into account in these studies. Therefore, it is important to assess the 
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prevalence of and risk factors for vitamin D deficiency in a representative sample 
women and men in urban and rural settings.  
 
1.3.5 Coffee, smoking, alcohol and bone 
 Caffeine is known to increase calcium excretion (Heaney & Recker 1982; 
Massey & Whiting 1993) and to reduce intestinal calcium absorption (Barger-Lux et al 
1995), with a net loss of approximately 5 mg calcium per cup of coffee (Heaney & 
Recker 1982). Animal studies suggest a delay of the osteogenic process in rats treated 
with coffee (Lacerda et al 2010). In a recent study, Hallström et al. found high 
consumption of coffee to reduce BMD of the femoral neck in elderly men (Hallstrom 
et al 2010). However, results from epidemiological studies investigating the relation 
between coffee consumption and BMD in both men and women have been conflicting 
(Atalar et al 2009; Cauley et al 2005; Glynn et al 1995; Hannan et al 2000; Johansson et 
al 1992; Patel et al 2003; Reyes et al 2004; Ruffing et al 2006).  
 Cigarette smoking was identified as a risk factor for osteoporosis more 
than 20 years ago. Studies show a direct relationship between tobacco use and 
decreased bone density. In addition, most studies suggest that smoking increases the 
risk of having a fracture. However, the interpretation of data is complex as smoking is 
associated also with other life style factors e.g. alcohol and dietary habits and also 
with reduced estrogen levels and early menopause in women (Maurel et al).  
 The influence of alcohol on bone is controversial and the effect seems to 
be dose-dependent. Light alcohol consumption (1-10 g of ethanol per day) has been 
suggested to have positive effects whereas heavy consumption (30 g of ethanol per day) 
may reduce bone mass due to a bone remodeling imbalance, with a predominant 
decrease in bone formation. Alcohol seems to increase osteocyte apoptosis and oxidative 
stress, and also to modulate the Wnt signaling pathway. Moreover, in heavy drinkers 
reduced total fat mass, increased lipid content in the bone marrow and eventual hypo- 
leptinemia could be confounding factors. 
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1.4 VIETNAM – AN ASIAN COUNTRY IN RAPID DEVELOPMENT 
 
Figure 8. Map of Vietnam 
 Vietnam is a developing country situated in the South-East Asia with a 
rapid increase in population. From 24 millions in 1945, it increased to 57 millions in 
1975 (Vietnam historical demographic data of the whole country) and up to 90 million in 
2011. 
  Vietnam has had a long history of wars from a millennium of the Chinese 
dynasty era to many years under French colonization, and thereafter the Vietnam war 
against the USA. The French administration imposed significant political and cultural 
changes on the Vietnamese society. A Western-style system of modern education was 
developed and 
Vietnam’s population today is 9 times more than Sweden’s, while the area of 
Vietnam is just about two-thirds in comparison to this Nordic country. The population of 
Vietnam is large enough to make it the second most populous country in the South-East 
Asia, the seventh in the Asia-Pacific region and the 12th most populous in the world 
(General Statistics Office of Vietnam, 2012).  
Roman Catholicism was widely propagated within the society. Vietnam 
became independent in 1945, and was really united in 1975 after decades of war 
hardship and poverty.   
 Since 1986, Vietnam follows the “Doi moi” policy which is a revolution 
strategy to promote the transition from a planned economy into a "socialist-oriented 
market economy”. Private ownership was encouraged in industries, commerce and 
agriculture (Vuong et al, 2009). Thanks largely to these reforms, Vietnam achieved an 
about 8% annual GDP growth between 1990-1997 and the economy has continued to 
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grow at an annual rate of around 7% from 2000-2005, making Vietnam one of the 
world's fastest growing economies. According to a 2008 prognosis by 
PricewaterhouseCoopers, Vietnam may be the fastest growing of the world's emerging 
economies by 2025 (Vietfinancenews.com. 29 December 2010)
 During the last 50 years, the inhabitants’
.  
 average life span has increased by 
33 years from only 40 years in 1960. In comparison the world average life span has 
increased by 21 years. The infant mortality has rapidly declined from 157 in 1950 to 70 
in 1975 and down to 20 per 1,000 live births in 2011 (UN, 2011).  
 Vietnam is located between the latitudes 8° and 24°N, and the longitudes 
102° and 110°E. The differences in latitude cause a marked variation of the climate. In 
northern Vietnam, the seasonal variations between winter/dry season (November to 
April) and summer/rainy season (May-October) are more pronounced than in the 
southern part of the country.  
 Osteoporosis is often considered as a consequence of industrialization, 
because the incidence of osteoporotic fractures is higher in industrialized countries than 
in developing countries (Lau et al 2001).  Furthermore, within a country, the incidence 
of fractures is higher in urban than in rural communities (Chevalley et al 2002; Madhok 
et al 1993; Mannius et al 1987; Sanders et al 2002).  Clearly, studies on osteoporosis in 
emerging developing countries are important to provide more information on the 
evolution of the disease.  
 Due to recent economic development, Vietnam has undergone rapid 
urbanization and there is a clear separation between urban and rural areas. During this 
process, differences in life styles, dietary and working habits and also exposure to 
polluted air and environment have gradually developed between citizens living in 
different settings. Although osteoporosis is increasingly recognized as a major public 
health problem, there is currently a lack of knowledge about its prevalence. Furthermore, 
reference data on peak bone mass and risk factors to allow screening in these specific 
populations are not available.   
 
Capacity building through international collaborations is one of the key strategies 
to drive Vietnam to a better future  
 One of the important keys to drive Vietnam to a better future is to 
actively engage not only in international economic integration but also to expand 
international cooperation in other fields including research and education (Ministry of 
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Foreign Affairs, 2009)
 This project within the KIRT program started in 2003. The research 
education has been carried out both in Vietnam and in Sweden through joint 
Vietnamese and Swedish supervision. All the field work was done in Vietnam. The 
experimental work was done in Sweden, where standardized methods and 
experienced supervisors would assure reliable results based on the data. 
. In line with national strategies, the KIRT (Karolinska 
International Research Training) program between Karolinska Institutet (KI) and 
Hanoi Medical University (HMU) started in the year 2000. This program was entitled 
“pathogenesis, diagnosis, epidemiology and treatment of common diseases in 
Vietnam”. The aims of the program were to increase the research capacity in 
Vietnam, to enhance knowledge transfer and to update biomedical and clinical 
research in some selected fields of public health importance and mutual interest. The 
program was financed by Sida, both in Vietnam and in Sweden. 
 
 
Figure 9. The KIRT collaboration started in 2000 
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 The PhD student has been the key person in every step of the project 
development from the first design, planning to implementing and monitoring. The 
PhD student has learned not only in terms of knowledge and skills in the research 
field but also in other capacities such as to cooperate, coordinates and collaborate 
with other health care professionals and institutions in two different environments 
(Vietnam and Sweden).  During the research project work, the PhD student has 
formed her own research student group. This team, named as “FSH” (Friendship and 
Science for Health), has over the years held regular scientific seminars and 
discussions of research theory, research methods and health problems for the society. 
Several of these “scientific children” of hers have now become master and PhD 
students of their own and some currently work with their own projects in e.g. France, 
Holland, USA and also here at KI in Sweden. 
         
 
Figure 10. Friendship and Science for Health (FSH) research group 
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2 AIMS 
 
 The overall aims of this Thesis were to clarify to what extent osteoporosis 
could be regarded as a major public health problem in Vietnam. Furthermore, to 
elucidate the prevalence of certain risk factors and determinants of bone mass as a basis 
to indentify high-risk individuals among Vietnamese women and men.  
 
Specific aims 
• To determine peak bone mass in order to estimate the prevalence of osteoporosis 
in Vietnamese women and men. 
• To explore possible differences between urban and rural residents with respect to 
risk factors for low bone mineral density and osteoporosis.  
• To investigate the prevalence of vitamin D deficiency and the associations of this 
risk factor with bone mineral density in samples of Vietnamese women and men.  
• To measure sex steroid hormone levels in relation to bone mass among 
Vietnamese women and men. 
• To quantify the aglycone content in different soymilk preparations and to 
evaluate its potential for osteoporosis prevention. 
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3 MATERIAL AND METHODS 
  Hanoi map 
  Hanam map
 Figure 11. Studied sites: clinical materials were collected (I) from Dong 
Da and Soc Son in Hanoi (top panel) and (II & III) from Dong Da in Hanoi and Kim 
Bang in Hanam (bottom panel). 
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3.1 SUBJECTS AND SAMPLES (I, II, III) 
The clinical studies were designed as cross-sectional investigations using a 
multistage sampling scheme. Within the setting of northern Vietnam (latitude 21o
In paper I, we assumed that the peak BMD was 1 g/cm
N), for 
study I, two districts in Hanoi (Dong Da & Soc Son) and for studies II and III, two 
districts (Dong Da in Hanoi and Kim Bang in Hanam) were selected to represent urban 
and rural areas, respectively. From each of these districts, 4 communes were randomly 
selected, and a full list of all inhabitants was obtained from the local government 
authority, which served as the sampling frame.  The lists of inhabitants were then sorted 
by age in 10-year groups.  For each age group, a total of 100 women (I) and a total of 
140 individuals (70 women, 70 men) (II & III) were randomly selected by a computer-
generated numbers and invited for screening interview.  
2 with a standard 
deviation of 0.1 g/cm2
For paper II, based on published literature (Holick 2007; Mithal et al 2009), 
where the prevalence of vitamin D deficiency in the world populations ranged between 
30-50%, we estimated that a sample size of 170 individuals would be adequate to 
calculate the prevalence within 8 percentage points of the true proportion with a 95% 
confidence.  
, then the required sample size was about 120-150 women aged 
between 10 and 49 years. In order to estimate the prevalence of osteoporosis in women, 
we aimed to recruit at least 400 individuals. Among the 400 women randomly selected, 
373 women (response rate of 93%) agreed to participate in the study.  However, after 
excluding women who did not meet the study entry criteria, only 168 women were 
finally included in the study.  A further random sample of women aged between 50 and 
65 from the same communes were invited to participate in the study for estimating the 
prevalence of osteoporosis.  In this sampling scheme, women aged 50 and 65 were 
randomly selected from all communes. Initially 386 women agreed to participate in the 
study; however, only 160 women met all the inclusion and exclusion criteria.  In total, 
343 women aged between 10 and 65 were eligible for participating in the study.  
For paper III, based on published literature (Melton et al 1992), where the 
prevalence of osteoporosis in men ranged between 10-20%, we estimated that a sample 
size of 170 individuals would be adequate to calculate the prevalence within 6 
percentage points of the true proportion with a 95% confidence interval. In a subsample 
of at least 100 individuals (men ≥50 years of age)  the corresponding figure was 8 
percent. 
 22 
For paper II & III, a letter of invitation was sent to a total of 980 individuals, 
among whom 823 came for the screening. Screening interviews were performed at the 
local healthcare center by health professionals from Hanoi Medical University, and 
participants were offered a free health check-up. After screening, a total of 604 
individuals fulfilled the inclusion criteria, and among them 559 ultimately participated in 
the study. 
Exclusion criteria. Women and men were excluded from the study (I, II and 
III) if they had conditions that were deemed to affect bone metabolism such as chronic 
diseases (dysfunctions of liver, gut, kidney, endocrine system, respiratory or 
cardiovascular system, auto-immune diseases and cancer), or use of medications, or 
more than one month in bed, or premature menopause or hysterectomy/oophorectomy, 
or history of fracture. 
 
3.2 ETHICAL ASPECTS 
 The research protocol and procedures were approved by the ethics council 
of Hanoi Medical University (No. 05/IRB & No.97/HMU IRB). All participants were 
provided with adequate information about the objectives of the study and had given their 
oral informed consent to participate, according to the principles of medical ethics of the 
World Health Organization. 
  
3.3 DATA COLLECTION (I, II, III) 
 All participants were subject to individual interviews carried out at the 
National Cancer Hospital (I) or the Bach Mai hospital (II & III) by health professionals 
from Hanoi Medical University. Data were collected on age, clinical history, lifestyle, 
dietary habits, smoking, alcohol and coffee intake. Height without shoes (in centimeters) 
was measured by a wallmounted stadiometer. Weight, without shoes or clothing, was 
measured on an electronic scale. Body mass index (BMI) was then derived as the ratio of 
weight (kg) over height squared (in m2
 
).  
3.3.1 Bone mineral density measurement  
BMD was measured at the lumbar spine (LS), left and right femoral neck (FN) 
and total hip (TH) in all qualified subjects.  The measurements were done with a dual 
energy X-ray absortiometry (DXA) densitometer (GE Lunar Prodigy advance (I) and 
Hologic Explore 4500 (II & III).  The precision error (%CV) in our laboratory for both 
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machines was 1.8% for lumbar spine and 1.5% for hips. The machines were 
standardized by standard phantom every time before measurement.  In these analysis, 
BMD at the lumbar spine was estimated from L2 - L4 (I) or L1-L4 (II & III).  Femoral 
neck and total hip BMD used in the analysis were estimated from the right side. 
  
 
Figure 12. DXA densitometer (GE Lunar Prodigy Advance) 
 
 
Figure 13. Result report of DXA measurement 
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 In order to estimate peak BMD, a series of polynomial regression models 
(up to the third degree) were fitted to femoral neck, total hip and lumbar spine BMD as a 
function of age.  In these models, the expected value of BMD at each skeletal site was 
expressed as follows: BMD = α + β1(age) + β2(age)2 +β3(age)3, where α is the 
intercept, β1, β2, and β3
 To classify osteoporosis, from the peak BMD, a T-score, which is the 
number of standard deviations from the peak BMD, was calculated for each individual in 
the study sample.  The prevalence of osteoporosis was estimated for women aged 50+ 
(I), menopausal women and men aged 50+ (II & III).  An individual was classified as 
having osteoporosis if her/his femoral neck BMD T-score was equal or lower than -2.5 
(Kanis & Gluer 2000).  Standard error and 95% confidence intervals of the prevalence 
were estimated based on the assumption of binomial distribution.  
 are regression parameters to be estimated from the observed 
data.  Reduced models (i.e., quadratic and linear models) were also considered, and the 
“final” model was chosen based on the Akaike Information Criterion (AIC) (Akaike 
1973).  Peak BMD and age at peak BMD were estimated from the final model.  The 
95% confidence interval of peak BMD and age at peak BMD were determined by the 
bootstrap (resampling) method (Efron B & Tibshirani R 1986).  In this method of 
analysis, 1000 repeated samples, each with 300 individuals, were drawn from the 
original material. The cubic equation was fitted to each sample, and the 95% confidence 
of the 1000 values for peak BMD and age at peak BMD were then determined.  The 
analysis was performed with R environment (Carlberg & Molnar 2012) and the Design 
library (Harrell et al 1996).  
 
3.3.2 Serum analyses  
Blood samples were drawn in the fasting condition in the morning and 
centrifuged within 30 minutes after collection. Serum samples were frozen at -80oC until 
analysis. Serum concentrations of 25(OH)D,  PTH, estradiol-17β and testosterone were 
measured by electrochemiluminescence immunoassay (ECLIA, Roche diagnosis). The 
measuring range was from 4 to 100 ng/mL (10-250 nmol/L) and from 1.2 to 5000 pg/mL 
(0.127-530 pmol/L) for 25(OH)D and PTH, respectively. The intra-assay coefficient 
variation (CV) was 5.6% for 25(OH)D and 11.62% for PTH. The inter-assay CVs were 
9.9% and 11.9%, respectively. The intra-assay coefficient variation (CV) was 5.2% for 
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estradiol and 5.7% for testosterone. The inter-assay CVs were 9.2% and 9.9%, 
respectively. 
3.4 DATA ANALYSIS (I, II, III) 
Characteristics of the participants were presented as mean and standard deviation 
or median and range. For categorical data frequency counts and percentages were used. 
In comparisons between men and women, with respect to the characteristics of the 
participants, the t test for independent samples was used for continuous data and the 
Chi-square test for data measured on a nominal scale (II & III).  
For paper II, to find the most important factors predicting vitamin D deficiency 
(<20 ng/mL) both univariate and stepwise logistic regression analyses were performed. 
All regression analyses were done separately for men and women. The predictors were 
age classes, <30, 30-49, 50-59 and >60 years, height, weight, BMI, residency, season, 
smoking, alcohol- and coffee drinking and also for women contraceptive pill use. The 
results from the logistic regression were presented as odds ratio (OR) and 95% 
confidence intervals (CI). Furthermore, univariate and forward stepwise multiple linear 
regression analysis was used to evaluate to what extent the variation in different BMD 
measures could be explained by Vitamin D, PTH, age, height, weight, BMI, residency, 
smoking, alcohol- and coffee drinking and also for women contraceptive pill use. The 
results from the stepwise regression models were presented as unstandardized regression 
coefficient, 95% CI and R2
For paper III, to find the most important factors predicting osteoporosis (T-
score less than or equal to -2.5) both univariate and stepwise multinomial logistic 
regression analyses were performed (osteoporosis versus normal). The predictors were 
age, height, weight, BMI, residency, smoking, alcohol- and coffee drinking, levels of 
estradiol and testosterone. The results from the logistic regression were presented as 
odds ratio (OR) and 95% confidence interval (CI). Furthermore, univariate and forward 
stepwise multiple linear regression analysis was used to evaluate to what extent the 
variation in different BMD measures could be explained by estradiol, testosterone, age, 
height, weight, BMI, residency, smoking, alcohol- and coffee drinking. The results from 
the stepwise regression models were presented as the unstandardized regression 
coefficient, 95% confidence interval (CI) and R
. A p-value <0.05 was considered statistically significant.  
2
 
. A p value <0.05 was considered 
statistically significant.  
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3.5 EXPERIMENTAL STUDY (IV)  
3.5.1 Samples 
 Commercial soymilk products: Six different brands of soy-milk drinks 
commercially available in Vietnam (VN1-Vinamilk®; VN2- Vinasoy®; VN3-Unisoy®) 
and Sweden (S1-Provalmel®; S2-Gogreen®; S3-Alpro®
 “Home-made” soymilk prepared at the laboratory: Soymilk was 
prepared from beans of different origin R1-2 (US); R3 (UK) and R4 (Vietnam). 100 g of 
whole dry soybeans and 1000 mL of tap water were mixed in a common soymilk 
homogenizer (Soja-queen, Miko, GmbH, Frankfurt, Germany). The original processing 
time for homogenizing and heating at 80
) were purchased from local 
supermarkets. According to package labeling, all products were manufactured within the 
last 30 days. In Vietnamese soymilk, the protein and total fat content ranged 1.5-2.6 
g/100 ml and 0.8-1.5 g/100 ml, respectively. The corresponding values for Swedish 
soymilk were 3.0-3.7 g/100 ml and 1.9-2.2 g/100 ml. 
o
 
C was 18 min (R1). For preparations R2-4, 
heating was prolonged until 3 hours.  Each soymilk preparation was freezed-dry in 10 ml 
aliquots until extraction.  
 
Figure 14. 10 different preparations of soymilk were analyzed by HPLC 
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3.5.2 Methods 
 Isoflavone extraction from soymilk: Frozen dried samples from 20 ml 
soymilk were used for extraction as described by Griffth et al, (2001) and Apers et al, 
(2004); with modification. Isoflavone calculation was based on 10 ml of soymilk. 
Samples were extracted in 50 mL of 80% methanol heated at 800
 All samples were immediately filtered (Munktell's Swedish paper No 8) 
into disposable tubes, and centrifuged at 300 x g for 20 minutes. The mobile phase was 
evaporated under a steam of nitrogen at 55-60
C and simultaneously 
shaken at 100 rpm in water bath (Heto, Denmark) for 60 minutes.  
0C to complete dryness. Dried samples 
were kept at -200
 Prior to injecting into the column, sample extracts were re-suspended in 
1mL of acetonitril 16%, vortex-mix and centrifuged at 13000 x g for 20 min. 500 µl of 
supernatant of each sample was transferred into a clean HPLC vial and analysed for their 
aglycone and glycoside concentrations.  
C until analysis by reverse phase high-pressure liquid chromatography 
(HPLC).  
 HPLC quantification of isoflavones: HPLC was carried out on a 4 mm x 
150 mm C18 reverse phase column (Reposil-pur Column C18-AQ), 5 mm packing (150 
mm x 4 mm ID, 70306-21004, R15.AQ. S1504, Ammerbuch) with an auto sampler 
(Basic Marathon type 816, Netherlands) to inject 50 µl of sample and flow rate of 0.8 
mL/min. Mobile phase was prepared as follows: Solvent A, 0.1% (V/V) acetic acid in 
water; Solvent B, 0.1% (V/V) acetic acid in 90% HPLC-grade Acetonitrile. The solvents 
were filtered through a 0.45 µm filter. The gradient was started immediately upon 
injection. The gradient elution program was: 
0                        95            5 
Time (min)      A%         B% 
3                        95            5 
4                        80           20 
6                        80           20 
10                      70           30 
12                      70           30 
13                      65           35 
15                      65           35 
20                      60           40 
30                      50           50 
32                      95            5 
33                      95            5  
36                      95            5  
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Total sample to sample time was 36 min for this method. Detection was by 
UV absorbance at 250 nm. The peak areas were integrated for quantization by 
CSW32 chromatographic station program for windows.  
After injection of 50 µL standards and extract samples, elution was 
monitored at 250 nm, and recorded over the time of run on all samples. The 
retention times (min) of our standards were as follow: Daidzin (12.18); Glycitin 
(12.44); Genistin (14.22); Daidzein (18.74); Glycitein (19.13); and Genistein 
(24.23) (Figure 1). Isoflavones were identified by comparing spectral data 
retention times to those of standard references. 
Isoflavones standards: Daidzin (C21H2009) from Fluka; Daidzein 
(C15H1004), Genistin (C21H20010), Genistein (C15H1005), Glycitein (C16H1205) 
from Sigma; Glycitin (C22H22010
Chemicals and Reagents: Acetonitrile, methanol, dimethylsulfoxid 
(DMSO), acetic acid (HPLC grade), and filters from Sigma-Aldrich Fine 
Chemicals, St.Louis, MO, USA, Milipore water were used for all mobile phases.  
) from Fisher; The internal standards 
Formononetin from Fuka. All these standards were purchased from Sigma-Aldrich 
Fine Chemicals, St.Louis, MO, USA. 
Calculation of isoflavone levels: The amount of isoflavone was calculated 
from the sample peak area calibrated against the peak area of standards (Figure. 1). 
Formononetin was used as an internal standard. The total isoflavone content was 
calculated as the sum of 6 isoflavones (daidzin, daidzein, glycitin, glycitein, 
genistin and genistein). All data were mean values from duplicate measurements. 
The intra-assay variation (n=35) was 2.1% and the inter-assay variation (n=35) 
was 3.1%. 
The theoretical maximum yield of aglycone after total transformation of its 
glycoside was calculated as: amount of glycoside (mg/L) / glycoside MW x  
aglycone MW.  
 
3.5.3 Statistical analysis 
 All data were expressed as mean from duplicate measurements. Differences between 
products from Vietnam, Sweden and “home-made” soy drink were analyzed by 
Kruskal-Wallis ANOVA followed by Mann-Whitney Utest. Correlations were 
assessed using Spearman's rankorder correlation. A p-value < 0.05 was considered 
statistically significant. 
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4 RESULTS 
 
4.1 CHARACTERISTICS OF PARTICIPANTS (I, II & III) 
In total, 328 women aged between 10 and 65 years were enrolled into study I. 
Out of these 328 women, 49% were aged 50 years or older.  Mean values for weight and 
height of the different age groups (Table 1) were similar to the normal range as reported 
for Vietnamese women  (Le 2003).  BMD measurement at each site (LS, TH, FN) was 
significantly and independently correlated with height (r = 0.42; p<0.0001) and weight 
(r = 0.46; p<0.0001).  Lumbar spine BMD was significantly correlated with total hip 
BMD (r = 0.75; p<0.0001), which was in turn correlated with femoral neck BMD (r = 
0.94; p<0.0001).   
 
Table 1.  Characteristics of study subjects (I) 
 
Age group <20 
(n=58) 
20-29 
(n=36) 
30-39 
(n=37) 
40-49 
(n=37) 
50-59 
(n=136) 
60-65 
(n=24) 
Age (yr) 13.8±2.8 23.8 ± 2.9 34.1±2.4 32.6±2.8 55.4±2.5 60.8±1.4 
Weight (kg) 38.8± 9.2 46.1±4.9 48.8±5.8 50.6±7.2 44.4±6.7 44.3±8.4 
Height (cm) 146.6± 9.2 152.1±4.8 152.1±5.6 152.6± 5.8 148.7± 4.8 148.9±4.1 
BMI (kg/cm2 17.8± 2.8 ) 20.0 ±1.8 21.1±2.2 21.7±2.5 20.1±2.6 20.0±4.2 
 
BMD (g/cm2
 
) 
     
Femoral neck  0.81±0.13 0.9 ±0.11 0.89±0.12 0.89±0.12 0.73±0.10 0.69±0.06 
Total hip 0.87±0.15 1.00±0.10 0.98±0.12 1.00± 0.13 0.84±0.11 0.78±0.08 
Lumbar spine 0.93±0.16 1.11±0.12 1.12±0.17 1.08± 0.15 0.85±0.12 0.80±0.13 
*Values shown are mean and standard deviation 
   
  
 Studies II & III involved 222 men and 269 women aged between 13 and 
83 years (Table 2). There were no differences between men and women in terms of age 
and BMI. As expected, men had greater height and weight than women. The prevalence 
of smoking, alcohol and coffee consumption was several times higher in men than in 
women. 
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Table 2. Characteristics of participants (II & III) 
 
Variables Reproductive 
Women 
Menopausal 
Women 
Men 
N 118 151 222 
Age (yr) 34 (13-53) 59 (44-83) 49 (14-83)  
Weight (kg) 48 (32-65) 49 (34-68) 53 (35-85) 
Height (cm) 155 (143-166) 152 (134-168) 164 (148-181) 
Body mass index (kg/m2 20 (14-26) ) 21 (15-30) 20 (15-31) 
 
Current smoking* 0 (0%) 1 (1%) 96 (43%) 
Alcohol drinking* 4 (3%) 7 (5%) 124 (56%) 
Coffee drinking* 14 (12%) 7 (5%) 46 (21%) 
 
Number of Children 2 (0-5) 4.0  (0-10) na 
Breast feeding* 81 (70%) 142 (94%) na 
Oral contraceptive use* 16 (14%) - na 
Fracture history* 8 (7%) 10 (7%) 10 (5%) 
 
Estradiol (pg/mL) 128.2 (95.9) a,b 45.1 (66.9) 42.8 (12.46) 
Testosterone (ng/mL) 0.45 (0.77) a,b,c 0.24 (0.74) 6.2 (2.25) 
 
BMD, femoral neck (g/cm2) 0.77 (0.09) a,c 0.63 (0.09) 0.76 (0.12) 
BMD, total hip (g/cm2) 0.84 (0.09) a,c 0.73 (0.10) 0.85 (0.12) 
BMD, lumbar spine (g/cm2) 0.93 (0.10) a,c 0.75 (0.13) 0.90 (0.14) 
For age, weight, height, and BMI, values are given as median and range (in brackets), for 
estradiol, testosterone, and BMD, values are given as mean and standard deviation (in brackets) 
and for *categorical variables, values are given as number and percentage (in brackets). 
a p<0.05 between reproductive  and menopausal women. b p<0.05  between reproductive women 
and men. c
 
 p<0.05 between menopausal women and men 
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4.2 PEAK BONE MINERAL DENSITY IN VIETNAMESE WOMEN AND MEN 
 
4.2.1 Reference curve for bone mineral density in Vietnamese women (I 
& II) and men (II) 
 
 In women, as expected, BMD at the lumbar spine, total hip and femoral 
neck rapidly increased during the adolescence and  then gradually declined after the age 
of 40 (Fig 15 & 16). The equations that best described this trend were a third degree 
polynomial function of age as follows:  
 
Femoral neck BMD = 0.3353+0.0508×Age –0.0013×Age2+0.000009×Age
Total hip BMD = 0.3582+0.0532×Age –0.0013×Age
3 
2+0.000009×Age
Lumbar spine BMD = 0.1236+0.0855×Age –0.0022×Age
3 
2+0.0000155×Age
 
3 
 These equations accounted for 36%, 30% and 47% of the variation at the 
femoral neck BMD, total hip and lumbar spine, respectively. The regression coefficients 
suggest that the increase in BMD during the adolescence was greater at the lumbar spine 
than at the hip (0.085 vs 0.05 g/cm2); however, the subsequent decrease in BMD was 
also greater at the lumbar spine than at the hip (0.0022 vs 0.0013 g/cm2
 
). For any given 
site, BMD among those aged 50-65 years was reduced between 20% and 28% as 
compared to the peak BMD level.  
 The age-related decline in BMD in women was greater than that in men. 
For example, for the lumbar spine among women aged 70+ years there was a decrease of 
about 30%; but in men, the corresponding rate of decrease was only around 15%. A 
similar sex-differentiated decline was also observed in femoral neck BMD. 
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(a) 
 
(b) 
 
(c) 
 
Figure 15. Relationship between age 
and BMD at femoral neck (a) total hip 
(b) and lumbar spine (c), in Vietnamese 
women. (I; Lunar Prodigy Advance) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Relationship between age 
and BMD at femoral neck (a), total hip 
(b) and lumbar spine (c) in Vietnamese 
women (violet circle and line) and men 
(orange dot and line). (II & III; Hologic 
Explorer) 
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4.2.2 Peak bone mineral density in Vietnamese women (I & II) and men 
(II) 
 
 Estimates of peak BMD (pBMD) and the age when pBMD was reached 
(Table 3) were based on a bootstrap analysis. In women, the pBMD values as measured 
by Lunar prodigy advance (I) for the lumbar spine and total hip were 1.16 g/cm2 (SD 
0.13) and 1.02 g/cm2 (SD 0.12), respectively. The age at pBMD was around 29 years.  
The corresponding value for pBMD at femoral neck was slightly lower [0.94 g/cm2
 A similar trend was also observed for BMD data measured by Hologic 
explorer (II). The absolute values of pBMD were highest for the lumbar spine, then for 
the total hip and lowest for the femoral neck. The age at the peak was higher for the total 
hip compared to the femoral neck and lumbar spine. The absolute values of BMD 
measured by Hologic explorer were lower than those measured by Lunar prodigy 
advance.  
 (SD 
0.11)] and the age at pBMD was around 28 years.  
 As expected, pBMDs at femoral neck and total hip were higher in men 
compared with women and approximately 0.05 g/cm2
 
 (about 5.8-6.3%). However, 
pBMD at the lumbar spine was quite similar between men and women. The age at 
pBMD for different bone sites also were similar for the two sexes.  
Table 3. Peak bone mineral density (pBMD) and age at pBMD in women and men (I, 
II) 
Bone site  Paper I  Paper IV 
 pBMD  
(with Lunar) 
Age at 
pBMD 
                 pBMD 
   (with Hologic) 
Age at 
pBMD 
Women     
Femoral neck  0.94 (0.11) 27.7 0.80  (0.10) 25 
Total hip 1.02 (0.12) 29.3 0.86  (0.10) 32 
Lumbar spine  1.16 (0.13) 28.5 0.98  (0.11) 30 
Men     
Femoral neck  -  0.85  (0.11) 25 
Total hip -  0.91  (0.12) 30 
Lumbar spine  -  0.97  (0.11) 32 
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4.3 PREVALENCE OF OSTEOPOROSIS IN VIETNAMESE WOMEN AND 
MEN (I & III) 
 Using the estimated peak BMD and standard deviation, femoral neck T-
scores were calculated for each woman and man, and the prevalence of osteoporosis 
(i.e., T-scores ≤ -2.5) (Kanis & Gluer 2000) was estimated as shown in Table 4.   
 For women aged 50-65 years, approximately 23% were classified to have 
osteoporosis at the femoral neck (I).  The prevalence increased with advancing age such 
that among those aged between 50 and 59 it was estimated at 21% and increased to 33% 
in those aged 60-65 years or above. The calculation for osteoporosis at the lumbar spine 
was 49% for women aged 50-69.  
 For menopausal women (III), the prevalence of osteoporosis was around 
17-18% for the femoral neck and total hip; and approximately 37% for the lumbar spine. 
As expected, the prevalence of osteoporosis among men ≥ 50 years of age was lower 
than in women. It ranged from 7 to 12% for the different sites measured.  
 There was discordance in the diagnosis of osteoporosis as based on T-
scores between the femoral neck and total hip (I).  When the total hip BMD T-score was 
used, the prevalence was 26%.  However, when either femoral neck or total hip BMD 
was used, the prevalence increased to 34% in women aged 50-65 years. Although the 
proportion of concordance in the diagnosis between the two BMD sites was 80%, the 
kappa statistic was 0.49 (95% confidence interval: 0.34 – 0.65, data not shown) which 
was significantly different from 0 (p < 0.0001).   
  
Table 4.  Prevalence (%) of osteoporosis by site of BMD measurement in women 
and men 
Bone site Women (I & III)      Men (III) 
 50+ 
(n=160) 
 menopausal 
(n=151) 
 50+ 
(n=106) 
 
Femoral neck 23.1  17.9  8.5  
Total hip 25.6  16.6  6.6  
Lumbar spine 49.0  37.3  12.4  
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4.4 DETERMINANTS OF BONE MASS (II & III) 
 
4.4.1 Vitamin D deficiency and association with bone mineral density in 
Vietnamese women and men (II) 
 
4.4.1.1 Prevalence of vitamin D deficiency in women and men 
As shown in Table 5, serum levels of 25(OH)D and PTH were significantly 
higher in men than in women. The prevalence of vitamin D deficiency (defined as 
25(OH)D < 20 ng/mL) was twice as large in women and reached 30% in comparison 
with 16% in men.  
 
Table 5.  Levels of vitamin D and PTH (mean & SD); and number of individuals with 
vitamin D deficiency (%) in women and men (paper II) 
Variable Women Men P – value 
N 269 222  
PTH (ng/L) 29.1 (11.2) 31.8 (13.5) <0.05 
25(0H)D (ng/mL) 23.2 (7.4) 28.6 (8.9) <0.001 
25 (OH) D < 20 ng/mL 82 (30.5%) 35 (15.8%) <0.001 
 
4.4.1.2 Levels of vitamin D in different age groups in women and men 
Levels of vitamin D differed significantly between age groups in both women 
and men (Fig 17). In women the lower levels of vitamin D were found to be highest in 
the age groups younger than 30 years, as well as in women older than 60 years compared 
to those between 30-59 years (p<0.01). A similar trend was also observed in men, i.e. 
the lower levels of vitamin D were highest in the youngest age group (less than 30 years) 
compared to the older age groups (p<0.05).  
 
4.4.1.3 Levels of vitamin D by season 
The levels of vitamin D varied significantly by season (Fig 18). Levels of 
vitamin D were lower in the winter season (December and January) than in autumn 
(October and November) and summer (May and June) for both women and men 
(p<0.001). In the summer and autumn seasons, but not in the winter, the levels of 
vitamin D were significantly higher in women than in men (p<0.01, respectively). 
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Figure 17. Vitamin D concentrations (ng/mL) by age and sex. 
            (women violet and men orange color) 
                 
                 
Figure 18. Vitamin D levels (ng/mL, 95% CI) by season and sex.  
                                (women violet and men orange color) 
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4.4.1.4 Levels of vitamin D  - urban versus rural residence 
There were also markedly lower levels of vitamin D among women and men 
living in urban areas than in rural areas (p<0.001) (Fig 19). In urban areas the levels of 
vitamin D were similar for subjects of both sexes, while in rural areas they were 
significantly lower in women than in men (p<0.001).  
                    
Figure 19. Vitamin D levels (ng/mL, 95% CI) by area and sex. 
                                   (women violet and men orange color) 
 
 Multiple linear regression analysis revealed that the strongest predictors of 
vitamin D deficiency in women were age less than 30 years (p<0.01) and living in an 
urban area (p<0.01), whereas the use of contraceptive pill was protective (p<0.01) (II). 
In univariate analyses, winter season (p<0.001) and coffee drinking (p<0.05) were also 
associated with vitamin D deficiency in women. In men, multiple regression analysis 
showed that winter season was the only significant predictor of vitamin D deficiency 
(p<0.01). In the univariate analyses, urban area (p<0.001) and younger age than 30 
years compared to middle age (50-59 years) (p<0.05) were also associated with vitamin 
D deficiency in men (II).  
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4.4.1.5 Levels of vitamin D and bone mineral density in women and men  
The relationship between serum levels of 25(OH)D, PTH and BMD was 
examined by multiple regression analysis in paper II and Fig 20. 
 
 
Figure 20. Levels of Vitamin D (ng/mL) and BMD (g/cm2) at femoral neck (upper 
panel) and lumbar spine (lower panel) in women and men (women violet and men 
orange color) 
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 Among women, serum levels of 25(OH)D were significantly associated 
with BMD in total hip in multivariate analysis (p<0.001) (II). Also, serum levels of PTH 
were associated with BMD in the femoral neck and the lumbar spine (p<0.001) (II). In 
men, there were positive associations between vitamin D concentration and BMD in 
both total hip and lumbar spine (p<0.001, respectively). Among predictors for BMD in 
women, age, body weight, residence, coffee drinking, serum levels of PTH and 
25(OH)D were estimated to explain around 40% of the variation in BMD at different 
sites. In men, significant predictors for BMD were age, BMI and vitamin D 
concentration.  
 
4.4.2 Urban and rural differences in bone mineral density and 
prevalence of osteoporosis (II & III) 
Overall the mean BMD values of urban women tended to be lower as compared 
with their rural counterparts. After menopause, this difference was significant (p<0.01) 
for BMD values at the femoral neck and total hip (Table 6).   
 
Table 6. BMD and Osteoporosis by different groups of women and areas. 
Variable Reproductive Women Menopausal Women 
 
N 
Urban 
(51) 
Rural 
(67) 
P  
value 
Urban 
(55) 
Rural 
(96) 
P  
value 
BMD, femoral neck (g/cm2 0.75 ) 0.78 ns 0.61 0.65 <0.01 
BMD, total hip (g/cm2 0.82 ) 0.85 0.08 0.69 0.75 <0.01 
BMD, lumbar spine (g/cm2 0.95 ) 0.91 0.08 0.77 0.74 ns 
       
Prevalance of osteoporosis at       
 femoral neck (%) - - - 20.0 17.0 <0.01 
 total hip (%) - - - 20.0 15.0 <0.05 
 lumbar spine (%) - - - 30.9 41.1 ns 
Data shown as mean values; *categorical variables, values are given as percentage 
 
Also, the prevalence of osteoporosis for these sites (III) was found to be higher 
among menopausal women from urban than rural areas (femoral neck 20% vs 17%, 
p<0.01; total hip 20% vs 15%; p<0.05). 
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In contrast, the mean BMD in men from urban areas and below 50 years of age 
was found to be somewhat higher than their rural counterparts at all three studied sites 
(femoral neck 0.87 mg/cm2 vs 0.81 mg/cm2, p<0.05; total hip 0.93 mg/cm2 vs 0.88 
mg/cm2, p<0.05; 0.97 mg/cm2 vs 0.91 mg/cm2, p<0.05). However, after 50+, only BMD 
values at lumbar spine of men in urban areas were significantly higher than the men 
living in rural areas (0.94 mg/cm2 vs 0.85 mg/cm2
 
, p< 0.01). Furthermore, there was no 
difference in the prevalence of osteoporosis between men from urban and rural areas 
(III). 
4.4.3 Sex hormone levels as determinants of bone mineral density in 
women and men (III) 
In men, serum levels of testosterone averaged 6.2 ng/mL and no apparent change 
by age was recorded (III). Average estrogen levels were similar to those of 
postmenopausal women and there was a positive association with increasing age (rs
Among predictors for BMD in men (Fig 21 and III), multiple regression 
analysis revealed age, BMI and blood levels of estrogen to be the most important factors 
and estimated to explain 41% of BMD at the femoral neck and 27% at the total hip. For 
BMD of the lumbar spine, age, BMI and testosterone levels were the most important 
predictors. Similarly, age, weight, BMI, levels of estrogen and testosterone predicted 
osteoporosis at the different sites in men. 
 = 
0.26; p < 0.001) (III). Values of BMD for femoral neck, total hip and lumbar spine in 
men were similar to those quantified in women at reproductive age but higher than in 
postmenopausal women (Table 2).  
In women, as expected, sex hormone levels and BMD were lower in menopausal 
subjects as compared to those of reproductive age (Table 2). When the hormonal status 
for women was controlled by splitting into reproductive and menopausal groups, 
different predictors for BMD appeared (III). For reproductive women, weight and 
residence were the most significant predictors for BMD at all three sites, and these two 
variables contributed to 12-14% of the BMD variation.  For the menopausal women, 
age, weight, and residence explained 40-46% of the variation (III). For the whole female 
population, multiple regressions revealed age, weight, residence, estrogen levels and oral 
contraceptive use as the most important predictors of BMD and estimated to explain 
around 50% of the variation at different sites (data not shown).  
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4.4.4 Low aglycone content in commercial soy drink products (IV) 
4.4.4.1 Commercial soymilk products 
  The composition and total content of isoflavone for each product are 
shown in Table 6. Most of the soymilk samples had a similar total isoflavone content 
(glycosides and aglycones) ranging 60-80 mg/L except S1. In the S1 preparation, the 
concentration was as high as 122 mg/L (p<0.001).  
The predominant isoflavones in all products were glycosides, accounting for 
around 80% of the total isoflavone content. Glycitein and genistein were the two most 
abundant aglycones, and levels found in all products except S1 were 3-6 folds higher 
than for daidzein (IV). In the S1 sample, levels of daidzein (p<0.001) and glycitein (p< 
0.01) were markedly higher whereas the amounts of genistein were similar to that of the 
other preparations in paper IV.   
Figure 21. Bone mineral density (g/cm2) of the femoral neck as a function of serum 
estrogen levels (elog of ng/mL) in a sample of Vietnamese men (orange line, dot) and 
women (violet line, circle) 
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Table 6. Isoflavone content (mg/L) of commercial soymilk products from Vietnam & 
Sweden 
 
S1 107.7 14.0 121.8 
S2 64.2 9.8 73.9 
S3 65.6 7.0 72.5 
 
4.4.4.2 “Home-made” soymilk 
 There was a large variation in total isoflavone and glycoside content in 
soymilk prepared from beans of different origins (p<0.001). The US bean based soymilk 
R2 had the highest total isoflavones, followed by the UK bean based preparation R3 
(p<0.001). The Vietnam bean based preparation R4 had the lowest amount of total 
isoflavones, which was less than half of that of the R2 (p<0.001). The differences were 
mainly due to the variation in the amounts of glycoside content (Table 7).  
 
Table 7. Isoflavone content (mg/L) of “home-made” soymilk prepared at the lab from 
beans of different origin. (Samples R2-4 were prepared with prolonged heating for 3 
hours at 80o
 
C).  
Total   
Product glycoside aglycone isoflavone 
R1-US 81.3 10.2 91.5 
R2-US 128.9 10.1 139.0 
R3-UK 86.5 11.7 98.1 
R4-VN 57.6 5.8 63.4 
 Total 
Product glycoside aglycone isoflavone 
VN1 54.0 7.2 61.1 
VN2 65.4 5.6 71.0 
VN3 71.2 6.3 77.5 
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 The amounts of individual and total isoflavones were markedly increased 
after prolonged heating in the R2 preparation. The total isoflavone content was 38% 
higher in the R2 than in the R1 sample, which was prepared from the same US beans 
according to the standard procedure. The difference was mainly attributed to an increase 
in the glycoside content whereas levels of aglycones were quite similar (Table 7).  
 
 The theoretical maximum yield of aglycone after total transformation of its 
glycoside in all investigated 10 preparations was low. The two US bean (R1 and R2) and 
the UK bean based preparations had higher total isoflavone content than all commercial 
products, except for S1. The isoflavone distribution in the different preparations was 
quite similar. The relative amounts of daidzein, glycitein and genistein were around 20-
30%, 35-45% and 30-40%, respectively. Among the three Vietnamese products, the total 
isoflavone content in VN1 was significantly lower than that in VN2 (p<0.05) and VN3 
(p<0.01). Among the Swedish samples, the content in S1 was significantly higher than 
in S2 and S3 (p<0.001, respectively). 
 
4.4.4.3 Total protein content and isoflavone levels 
 The amounts of total protein, total glycoside, total aglycone and total 
isoflavones for the ten different soymilk preparations are presented in Fig 22. 
 
                       
Figure 22. Total protein content and isoflavone levels in different soymilk 
preparations [samples from Vietnam (red), Sweden (black) and home made (green)] 
 44 
Total protein content of the commercial soymilk preparations from Vietnam was 
generally lower than for the Swedish and home-made products. Also, the amounts of 
glycoside and aglycone and total isoflavone were lower. However, there was no apparent 
relationship between the amount of total protein and the isoflavone content in different 
soymilk preparations. 
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5 DISCUSSION 
 
5.1 PEAK BONE MINERAL DENSITY IN VIETNAMESE WOMEN AND MEN 
(I & II) 
 Peak BMD values are important to calculate the T-score that is a basis for 
the classification of osteoporosis (WHO, 1994). Using different values of pBMD (mean 
and SD) will influence the number of individuals classified to have 
osteopenia/osteoporosis in a population. As illustrated in Table 10 and study I, values 
for pBMD of Vietnamese women and men (either measured with Hologic equipment in 
study II&III or with Lunar equipment in study I), were comparable with data from 
other Asian countries but somewhat lower than Caucasian data.  
 
Table 10.  Comparison of young adult bone mineral density (g/cm2
 
) of the femoral 
neck in women and men from different Asian countries (all measurements were 
done with the Hologic equipment) 
 
 
 
 
 
 
 
 
 
 
1(Ho-Pham et al 2011), 2(Wu et al 2003), 3
  
(Looker et al 1997) 
 Values for BMD measured with the Hologic densitometer (II & III) were 
lower at all three studied sites and also the peak was reached at different ages in 
comparison with data measured by GE Lunar (I; Table 3). Given the sampling variation 
and the lack of calibration between densitometers of the same brand, the differences 
among Asian populations seem insignificant (I; Table 10). Some of the differences in 
prevalence of osteoporosis could be partially due to the difference in bone densitometry 
technologies. However, the effect of measurement technology to diagnose osteoporosis 
 
Population 
 
Peak BMD at femoral neck (mean and SD) 
Women Men 
 
 
Vietnamese 0.80±0.10 II 0.85±0.11  
Vietnamese in urban city1 0.80±0.11   0.85±0.13  
Japanese
Chinese
2 0.83±0.12 
2 0.81±0.12 
na 
0.94±0.15 
 
White American 0.86±0.12 3 0.93±0.14  
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is likely to be small because the prevalence will be determined from BMD T-scores, and 
T-scores are standardized to the mean and standard deviation as obtained from each 
densitometer and each population. Still, potential differences between densitometry 
technologies could be important when repeated measurements are performed in the same 
individual. Therefore, longitudinal measurements to follow change in BMD should be 
carried out using the same equipment. 
  Peak BMD values in Vietnamese men were also higher than in women at 
the femoral neck and total hip in concordance with previous reports (Looker et al 1997; 
Wu et al 2003), but not for the lumbar spine. The age at pBMD was quite similar for 
both sexes. For the femoral neck the peak was reached about 3 years earlier than for the 
lumbar spine (Ho-Pham et al 2011; Looker et al 1997). Our data suggest that 
Vietnamese women may achieve their peak BMD at a later age (between 25 and 30 
years) than Caucasian women among whom the peak BMD was reached between 20-25 
years (Henry et al 2004; Nguyen et al 2001).  The underlying factors to explain this 
apparent difference are not fully clear.  However, it is well-known that Asian girls tend 
to have a later menarche (average age of 13 years) than Caucasian girls (12 years).  It is 
also possible that nutritional factors and lower levels of estrogen and other sex steroids 
may contribute to the difference.  
 After definition of the specific Vietnamese pBMD, we could now obtain 
more appropriate T-score values to have more precise diagnosis of osteoporosis in 
both women and men. The prevalence of osteoporosis classified by using the specific 
Vietnamese T-score was 17.9% for women and 8.5% for men. In comparison the 
corresponding figures when using the reference data from the manufacturer of the 
densitometer were 11% & 14.5% respectively. These marked differences illustrate the 
importance of using population specific data for the diagnosis of osteoporosis. 
 
5.2 PREVALENCE OF OSTEOPOROSIS IN VIETNAMESE WOMEN AND 
MEN (I & III) 
 BMD is an important predictor of future fracture (Cummings et al 2006; 
Marshall et al 1996; Nguyen et al 1993) and individuals with osteoporosis are at 
increased risk (Marshall et al 1996).  It has been shown that 65% of individuals with 
osteoporosis will sustain a fracture within the next 10-15 years (Kung et al 2007a); 
(Nguyen et al 2007).   
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 The data presented in Table 4 suggest that approximately a quarter of 
Vietnamese women aged 50+ suffer from osteoporosis and are at high risk of hip 
fracture. Even more women may have a risk for lumbar compression and pain as a 
consequence of osteoporosis in this site. Also among men aged 50+, a significant 
number of individuals with osteoporosis were identified. Thus, it seems clear that 
osteoporosis represents an important burden of public health in Vietnam.  
 A comparison between the prevalence of osteoporosis among women and 
men aged 50+ years as reported from different countries is presented in Table 10. 
  
Table 10.  Prevalence of osteoporosis among women and men aged 50+ years 
reported from different countries 
Population 
Prevalence (%) of osteoporosis at femoral neck 
Women postmenopausal / 50+ Men 50+ 
VietnameseI 23.1   na 
Vietnamese 17.9 III 8.5 
Vietnamese in urban city 28.6 1 10.0 
Vietnamese American 37.0 2 - 
Thai 29.5 3,  12.6 
Indonesian
Chinese
4 ~15.0 
5 10.1 
- 
- 
Chinese 31.2 6 10.4 
Hong Kong 49.67 - 6 
Japanese 17.0 8 - 
Korean 12.4 9 5.9 
Australia 21.0 10 - 
U.S White 20.0 11 6.0 
1(Ho-Pham et al 2011); 2 Marquez M, et al (Melton et al 2002); 2: Limpaphayom KK, et al 
(Limpaphayom et al 2001); 4Tirtarahardja G, et al (Tirtarahardja G et al 2006); 5 Wu XP, et al (McNutt et 
al 2003);  6 Lynn HS et al (Lynn et al 2005); 7Ho SC, et al. (Ho et al 1999); 8Iki M et al (Kaneki et al 
2001); 9 Yang SO, et al (Yang SO et al 2006); 10 Henry MJ, et al (Pasco et al 2000); 11 Looker A, et al 
(Looker et al 1997). I
 
Note that the estimate in this study was limited within the age range of 50 and 65 
years.   
Our material included only few women above 65 years of age, none in study I, 
and around 40 in study III. Therefore, it could be that the prevalence of osteoporosis has 
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been underestimated.  Even so, the prevalence (between 17-23%) is similar with reports 
from Australia (Pasco et al 2000) and America (Looker et al 1997) but lower than in 
Thai (Limpaphayom et al 2001) and Hong Kong women (Cummings et al 2006).  
However, the prevalence of osteoporosis in the present study appears to be substantially 
higher than in Chinese (McNutt et al 2003), Japanese (Kaneki et al 2001), Korean  
(Yang SO et al 2006) and Indonesian women (Tirtarahardja G et al 2006).   
While the peak bone mass of Vietnamese women was found comparable to that 
of other Asian girls, the prevalence of osteoporosis among women aged 50+ was still 
higher than in many other countries.  One possible explanation could be that of a cohort 
effect. Women aged 50+ were born and grew up during many years of war, when the 
country's economy was in great hardship and many women suffered from malnutrition 
which may have resulted in a low BMD.  In contrast, the younger cohort aged between 
20 and 30 years was born and raised after the independence in 1975, during which 
economic and nutritional conditions have significantly improved.  
 In summary, this study has, for the first time, provided an estimation of 
peak BMD in Vietnamese women and men of urban and rural residence. Among 
women, the values for peak bone mass in this study were found comparable to Asian 
data but the prevalence of osteoporosis was higher than in some other Asian and 
comparable to Caucasian populations.  In men, the peak bone mass was found somewhat 
lower than for other Asian and Caucasian populations, but the prevalence of osteoporosis 
was quite similar. These data in the future may be useful as a valuable reference base to 
diagnose osteoporosis and for the clinical management of its consequences within the 
Vietnamese society.  
 
5.3 DETERMINANTS OF BONE MASS (II & III) 
5.3.1 Urban and rural differences in bone mineral density and 
prevalence of osteoporosis (II & III) 
 A consistent trend in osteoporosis research has been that the incidence of 
fracture is higher in developed than in developing countries. Also within different 
countries, the incidence is higher in urban than in rural communities (Pongchaiyakul et 
al 2005). Although other factors may also be involved, BMD is generally regarded as the 
most important primary determinant of fracture risk (Pongchaiyakul et al 2005). 
 Here we found the overall mean BMD values of urban women to be lower 
as compared to women of rural residence. After menopause, this difference was 
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significant (p<0.01) for BMD values at the femoral neck and total hip (Table 6). Also 
the prevalence of osteoporosis for these sites (III) was found to be higher among 
menopausal women from urban areas.   
 
Figure 22. Field work in rural Vietnam. Courtesy of Reuters   
 
 
Figure 23. Modern Hanoi cityscape, courtesy of Wikimedia 
Working and living indoors and also air pollution in cities and as a consequence 
reduced sun exposure to the skin could contribute to a lower average BMD in urban 
women (Fig 22 & 23). However, in the present study we also found them to have lower 
levels of circulating estradiol than their rural counterparts. The explanation for this 
difference is not clear but it could possibly reflect differences in physical activity and 
dietary habits. Like tobacco smoking, heavy air pollution in large cities might eventually 
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reduce aromatase activity and thus estrogen synthesis (Barbieri et al 1986). None of the 
postmenopausal women used hormone replacement therapy. 
 
5.3.2 Vitamin D deficiency and association with bone mineral density in 
Vietnamese women and men (II) 
Although there is a lack of data, it is commonly believed that as consequence of 
less sun exposure, vitamin D deficiency is more prevalent in Caucasian than in tropical 
populations (Mithal et al 2009).  However, here we found that more than 30% of the 
women and 16% of the men in a Vietnamese population had serum levels of 25(OH)D 
below 20 ng/mL (50 nmol/L). In fact, the prevalence of vitamin D deficiency in our 
study was comparable to reports on Caucasian Americans in the USA (Looker et al 
2008). The variations in the prevalence of vitamin D deficiency might be due to 
differences in ethnicity, pigmentation, nutrition and sun light exposure.  
In our material, being a woman, of younger age, living in a city, and winter 
season were independent predictors of vitamin D deficiency.  The difference was more 
apparent among the women than for the men. This finding could possibly reflect an 
effect of different clothing practices on vitamin D synthesis (Ho-Pham et al; Mithal et al 
2009). Following the rapid economic growth and an increasing cultural influence from 
e.g. western countries, white skin may have become part of a modern “beauty concept”, 
especially attractive to the younger generation of women (Fig 24). The trend among 
younger people to try to avoid exposure to sunlight was also observed in a previous 
study on urban residents in Ho Chi Minh City (Ho-Pham et al).    
 
Figure 24. Clothing habits and air pollution may contribute to vitamin D 
deficiency in urban citizens. Courtesy of VietnamNet. 
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Urbanization is known as a predictor of low levels of vitamin D and has been 
identified as a risk factor for deficiency in previous reports from Asia and the Middle 
East (Harinarayan et al 2007). Both men and women more often work indoors compared 
to those in rural areas. Also, air pollution in cities could contribute by acting as a barrier 
against UV light. However, in women the prevalence of vitamin D deficiency was also 
high in rural areas, and significantly higher than in men. This may indicate that women 
in general are more prone to cover their skin with clothing than men. 
 There is no general consensus on which circulating levels should be 
representative for sufficient amounts of vitamin D, but certainly all authorities agree that 
a cut off level below 20 ng/mL is a strong indicator of deficiency (Heaney 2004; Holick 
& Chen 2008; Lips 2001; Mithal et al 2009). For levels >20 ng/mL, a plateau effect on 
e.g. bone markers has been suggested (Fig 25). Such low levels as <20 ng/mL have been 
clearly linked not only to osteoporosis but also to a variety of severe conditions like 
hypertension, other cardiovascular diseases and cancer (Bischoff-Ferrari; Giovannucci et 
al 2008).  
 
 
Figure 25. Relationship between serum 25(OH)D levels and the bone markers 
osteocalcin (left) and uNTx/Cr (right).  A threshold level is indicated after values > 20 
ng/mL adapted from (Sai et al 2011). 
 
 According to some authors, even levels below 30 ng/mL should be 
regarded as vitamin D insufficiency and still represent a significant risk factor. However, 
this notion is more controversial and uncertain (Mithal et al 2009; Prentice 2008). In the 
present material, more than 80% of the women and 60% of the men had 25(OH)D 
values below 30 ng/mL.  
Synthesis of vitamin D is dependent on solar radiation of the skin. Latitude and 
seasonal variations influence the amount of possible solar radiation that a population 
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may receive. Here, the prevalence of vitamin D deficiency was much more pronounced 
in blood samples collected during the winter season (December and January) than in 
samples from autumn (October and November) and summer (May and June). This 
difference was apparent in both women and men and there was a significant trend for 
seasonal variations. This finding is in agreement with several previous reports, and 
seasonal variations in 25(OH)D concentration have been found even in subtropical 
locations (Mithal et al 2009). Adjustment for seasonal variation would be important for 
the definition of threshold values for vitamin D deficiency in different populations.   
In women, the use of oral contraceptives was associated with a lower risk of 
vitamin D deficiency. Activated vitamin D is bound to a binding protein in the 
circulation and estrogen is known to stimulate the production of this protein in the liver 
(Riggs et al 2002). Furthermore, estrogen stimulates hydroxylation of vitamin D in the 
skin. By these two mechanisms oral contraceptives may enhance the levels of vitamin D. 
Vitamin D deficiency will increase bone resorption, cortical bone loss and the 
risk of fracture (Bischoff-Ferrari; Bischoff-Ferrari et al; Lips 2006; Mason et al). Age, 
gender, body weight, smoking, alcohol and coffee have been implied as other risk 
factors for osteoporosis (Grossman). Also, smoking, alcohol, and coffee consumption 
were more frequent in men. In the present material, serum levels of 25(OH)D were 
positively associated with BMD at different sites in women. In men, vitamin D 
concentrations were also positively associated with BMD at the total hip and lumbar 
spine. 
These results indicate the importance of sun exposure for vitamin D status. 
Serum levels of 25(OH)D and vitamin D deficiency were significantly associated with 
bone mass in both women and men. The high prevalence of vitamin D deficiency should 
raise the concern about bone health, including risk of osteoporosis and fracture within 
the Vietnamese society.  
 
5.3.3 Sex hormone levels as determinants of bone mineral density in 
women and men (III) 
Our study supports the notion that estrogen levels have a stronger association and 
are more important as predictors for BMD than testosterone in both men and women.  
The critical role of estrogen in bone metabolism of both sexes is consistent with 
reported data. While BMD in men was previously considered to correlate mainly with 
testosterone (Faustini-Fustini et al 1999), recent findings rather indicate a direct 
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correlation between BMD and estrogen than with testosterone in healthy men regardless 
of their age (Hoppe et al). In men, estrogens are produced via conversion from 
androgens by aromatase activity in peripheral tissues, including bone 
(Ongphiphadhanakul et al 1998). Apart from age and BMI, we found estrogen levels to 
be significantly predictive for BMD of the femoral neck and total hip in men. This is in 
agreement with a case report of an adult man with estrogen resistance caused by a 
mutation in the estrogen receptor gene (Smith et al 1994). While blood levels of 
testosterone were within the normal range, this man suffered from increased bone 
resorption and osteopenia (Smith et al 1994). 
Although estrogen was generally more important, we still found that testosterone 
remained a significant predictor for BMD at the lumbar spine. Men older than 50 years 
gained 8-14% of BMD at the lumbar spine but not at the femoral neck after receiving 
intramuscular testosterone therapy for moderate hypogonadism (Tracz et al 2006). 
Testosterone, like estrogen, appears to stimulate bone turnover, acting directly or 
indirectly via conversion of estrogen in human osteoblasts to increase androgen receptor 
expression and stimulate bone cell proliferation and mineralization (Tracz et al 2006).  
In summary, the present data confirm the high prevalence of osteoporosis in the 
Vietnamese population also in men, and that estrogen levels are essential for bone mass 
in both men and women. The results should have clinical implications and increase 
awareness about an important health issue within the Vietnamese society. 
 
5.4 CAN SOY INTAKE PREVENT AGAINST OSTEOPOROSIS? (IV) 
 
Treatment for osteoporosis for a long time was based on HRT but its long-term 
safety is currently questioned and uncertain (Hickey et al 2005). Bisphosphonates and 
selective estrogen receptor modulators (SERMs) e.g. raloxifene or tamoxifen offer 
alternative treatments. However, these drugs are relatively expensive and their 
affordability in developing countries, where 1.5 billion elderly (60 years and more) are 
estimated to be living by 2050 (Mirkin 2001), is limited. 
While many scientific panels have now reached a consensus on the effect of 
phyto-estrogen on cardiovascular disease prevention (Erdman 2000; J.H.C.I 2002; U.S 
1999), the same conclusions have not been reached for prevention and treatment of 
osteoporosis (Branca 2003; Weaver & Cheong 2005). There are conflicting data on the 
effectiveness of soy isoflavones on bone metabolism in postmenopausal women. A daily 
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intake of 500 mL of soymilk  containing 76 mg of aglycones showed favorable effects 
on BMD as compared to the same amount of soymilk containing less than 1mg in a two-
year randomized trial (Lydeking-Olsen et al 2004). In contrast, soy protein intake 18 mg 
+ 105 mg isoflavone aglycone equivalents showed no apparent effects on BMD (Kenny 
et al 2009). Contradictory findings have also been reported for bone turnover. Yamori et 
al showed that an isoflavone-rich test drink (40 mg of glycosides) reduced bone 
resorption (Yamori et al 2002); while others had found no such effect from intake of soy 
with a content of 135 mg of total isoflavones/day (Cheong et al 2007). The inconsistent 
findings may reflect insufficient amounts of bioactive phytoestrogen i.e. aglycones and 
individual variations in sensitivity and isoflavone metabolism (Cassidy et al 2006) 
In our study, most of the soymilk products had a total isoflavone content around 
60-80 mg/L (calculated maximum yield of bioactive aglycone as 40-50 mg/L). They 
contained only 10-20% of the bioactive alycones, which can be absorbed directly 
through the intestine. Even an individual with a high capacity to metabolize would need 
to consume several liters of soymilk per day in order to achieve a threshold of around 
90-120 mg/day of aglycones to be effective on bone (Ma et al 2008a; Wong et al 2009). 
Certainly, such consumption is not feasible in everyday life not even among high soy 
consumers as in Vietnam.   
A large variety of factors may influence soy bean isoflavone content e.g. type of 
bean, crop year, growing temperature and location of agriculture. The variation in 
isoflavone content among different commercial products could also reflect their storage 
and processing (Eisen et al 2003; Lee et al 2003; Mathias et al 2006). The “home-made” 
soymilk (R1 and R2) from beans of US origin was found to provide a higher total 
isoflavone content than most of the commercial products. In this study, the commercial 
VN1 product was prepared from the same source of US beans, and therefore, the 
difference in isoflavone between the US bean and VN1 preparation was likely due to 
differences in processing. For the “home-made” preparation, the whole beans including 
the hull were used whereas in the industrial process VN1 was prepared after removing 
the hull (manufacturer personal communication). The hull of soy-bean itself has a very 
low isoflavone content but its removal may cause loss of the hypocotyl axis, which is a 
major source of soy aglycones (Wong et al 2009). 
We found prolonged heating for 3 hours to markedly enhance the β-glucoside 
content of the “home-made” soymilk preparations. In R2 as compared to R1, the total 
isoflavone content increased by 38%. Heating soymilk at 800C will convert the 
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conjugated malonyl-glucosides into the non-conjugated β-glucosides, which have the 
potential for further transformation into active isomers. Also, prolonged heating did not 
change the aglycone content, which is in agreement with previous data (Xu et al 2002).  
The present study found considerable variation in total isoflavone content when 
soymilk was prepared from beans of different origins and the differences were mainly 
due to glycoside amounts. Previous studies have also shown significant variations in the 
content of active aglycones and their glycosides in different commercially available soy 
foods in the US, Australia and Korea (Lee et al 2003; Setchell & Cole 2003).  
Long term storage of soy beans has also been suggested to change the isoflavone 
profile probably due to the reduction of the amount of malonyl-glycosides (Lee et al 
2003). It is possible that differences in duration and conditions of storage could explain 
the overall low isoflavone content and the poor effect of long-term heating to increase 
the glycosides in the sample of Vietnamese beans (R4).  
Given the increasing interest and consumption of soy products, there is an 
apparent need to establish universal guidelines and uniform industry standards for 
labeling of aglycone content. At present, consumers and health professionals are 
confused about what types and amounts of different soy consumables might confer any 
beneficial health effects. The food labeling claim for soy protein in prevention of 
coronary heart disease has been approved by many health authorities e.g. in the US, UK, 
France, and Asian countries but has also been seriously questioned (Sacks et al 2006; 
Xiao 2008). Variations in the content of active aglycones and their bioavailable 
glycoside isomers in different products could well account for many of the 
inconsistencies in reported outcomes from observational and clinical studies.  
It is often suggested that the isoflavone content of a soy product can be deduced 
from information of total protein content. The present study showed that such 
assumptions may not be justified. We found no apparent association between total 
protein and its isoflavone content in the different commercial and “home-made” soymilk 
preparations.  
Accurate labeling of soy food in general and soymilk in particular would be a 
major step forward to support consumers worldwide. Such a measure would also allow 
health professionals and researchers to better explore the health benefits and risks of soy 
in dietary intervention studies. 
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5.5 CRITICAL ASSESSMENT AND FUTURE PROSPECTS 
 The present results should be interpreted in relation to some strengths and 
weaknesses. The sample was randomly drawn from the general population after careful 
screening, which should support its representativeness and external validity. The sample 
size was statistically adequate to estimate a prevalence of osteoporosis between 10-20%.  
The use of DXA technology with reliable measurement of BMD is also a strength of this 
study. However, the design was cross-sectional and therefore the estimate of pBMD and 
age at pBMD could be subject to uncontrolled bias. Ideally, these values should be 
determined in a representative cohort which should be followed from 5 years to 30 years 
of age. However, it is unlikely that such a study is feasible and therefore, a cross-
sectional study is an alternative design. The estimated osteoporosis prevalence in post-
menopausal women in study I was based on a rather small sample size, particularly 
among those aged 60-65 (n = 24), which could result in an increased sampling error.  
Because the maximum age of participants in this study was 65, the osteoporosis 
prevalence could have been underestimated. Studies on larger numbers of both old 
women and old men are needed in the future. 
This is one of the largest studies of vitamin D status in the Asian population. 
Therefore, the estimates of vitamin D deficiency in age- and sex-subgroups would seem 
quite reliable. The results could probably be generalized for both urban and rural settings 
at least for the northern part of the country. The study population was highly 
homogeneous, which reduces the effects of potential ethnic confounders that could 
compromise the estimates. Nevertheless, the study has some potential weaknesses. 
Levels of 25-hydroxyvitamin D2 (ergocalciferol) and 1,25(OH)D were not measured in 
this study. However, the occurrence of these vitamin D metabolites in blood is very low 
and levels of 25(OH)D are considered to adequately reflect vitamin D status. This was a 
cross-sectional study, so no causal inferences could be made for the observed 
relationships between factors.  
To the best of our knowledge, this is the first study to investigate the correlation 
between sex steroid hormones and BMD in a Vietnamese population. The clinical 
material comprised both men and women randomly recruited from both rural and urban 
areas according to a rigorous selection scheme. Furthermore, the present study 
population had a wide age range from 13-83, which allowed the comparison of the 
relation between sex hormones and BMD in different age groups. Nevertheless, the 
study had clear limitations. Serum levels of the important sex hormone–binding globulin 
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(SHBG) were not quantified; and thus, the concentrations of free sex steroid hormones 
which are bio-active at target tissues could not be evaluated (Elmlinger et al 2005). In 
addition, as the study design was cross-sectional, conclusions on the long-term influence 
of sex hormones on BMD could not be drawn. Ideally, this relationship should be 
determined in a representative cohort in which a large number of men and women are 
followed.  
The aglycone content of commercial soy drinks was analyzed in only a small 
sample of products. This pilot study should be expanded to larger materials and also 
performed for other forms of soy food e.g. tofu and soy powder. Still, analyses were 
performed with HPLC, a high quality technique with high sensitivity. The conclusion 
that currently available commercial soymilk products contain low amounts of aglycone 
is unlikely to change. So, it seems that unless new products become available, a strategy 
to promote soy food intake would have only little influence to prevent osteoporosis.  
 
5.6 PUBLIC HEALTH AND CLINICAL IMPLICATIONS 
Osteoporosis is an important health problem in both women and men in the 
Vietnamese society. Accurate diagnosis is dependent on relevant data for BMD from the 
specific population that should be monitored and eventually be subject of intervention.  
In the present work, such early reference data have been presented. However, in 
the future, even larger numbers of individuals should be examined by densitometry to 
further establish accurate reference values for the population. 
Vitamin D deficiency has been linked to osteoporosis, and also to risk of cancer, 
autoimmune disorders and cardiovascular diseases (Bischoff-Ferrari; Cutolo & Otsa 
2008; Holick 2004). The high prevalence of vitamin D deficiency in the present material 
should raise the awareness of potentially important health issues within the Vietnamese 
society. Young women in urban areas may be an especially important target group for 
information about possible risks associated with vitamin D deficiency. Efforts to change 
attitudes towards sun exposure and the perception that white skin is a mark of 
attractiveness and a measure of high social status should be carried out. Defining 
resident groups at risk for vitamin D deficiency should be important to stimulate 
prevention strategies employed in a clinical setting. Vitamin D supplementation, 
increased exposure to UV light, fortification of food products with vitamin D and 
recommendations for better dietary intake could all be important tools and help to reduce 
potential health problems on a national level. 
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Estrogen levels are essential for bone mass in both men and women. In the 
clinical setting, both sex steroid hormones, estrogen and testosterone should be 
investigated for both men and women with osteoporosis. To the general public, 
information on possible risks associated with reduced sex hormone levels e.g. from 
smoking should be given. 
Rural citizens have better bone mass when compared with their urban 
counterparts. Thus, a healthy lifestyle as in some rural communities should be promoted 
e.g. the importance of healthy nutrition, moderate physical activity and a clean 
environment should be emphasized. 
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6 GENERAL CONCLUSIONS 
This Thesis has, for the first time, presented 
• Reference values for pBMD in Vietnamese women and men. These data 
allowed the calculation of T-scores and thus an accurate identification of 
osteoporosis. Among women, values for pBMD in this study were found 
comparable to other Asian data but the prevalence of osteoporosis was higher 
and comparable to Caucasian populations.  In men, the pBMD was found 
somewhat lower than for other Asian and Caucasian populations, but the 
prevalence of osteoporosis was quite similar. As determined at the femoral neck, 
the prevalence of osteoporosis in women was 17-23% and for men 9%. Even 
more women (37-49%) may have a risk for lumbar compression and pain as a 
consequence of osteoporosis in the spine. These data clearly suggest that 
osteoporosis is an important public health problem. In the future, our results 
may be useful as a valuable reference base to diagnose osteoporosis and for the 
clinical management of its consequences within the Vietnamese society.  
• Significant predictors of BMD in men were age, BMI, and serum levels of 
estrogen. In postmenopausal women, age, weight and residence (urban vs rural) 
were the most important predictors. Postmenopausal women living in urban 
areas experienced osteoporosis more than rural residents. For all women, also 
blood levels of estrogen and testosterone were significant determinants.  
• Serum levels of 25(OH)D were significantly associated with bone mass in both 
women and men. The prevalence of vitamin D deficiency, even when using the 
low cut off value of < 20 ng/mL, was very high and estimated to 30% in women 
and 16% in men.  Partly this finding might be explained by low exposure to 
sunlight (urban residency and winter season) especially in women younger than 
30 years of age. The high prevalence of vitamin D deficiency should raise the 
awareness of potentially important health issues such as osteoporosis but also 
about other serious diseases within the Vietnamese society.  
• The total isoflavone content of different soymilk preparations were low, around 
60-80 mg/L and there were only 10-20% of bioactive aglycones. This is far 
below the reported threshold levels to exert significant effects on bone. 
Consumption of several liters of soymilk per day would be needed to achieve 
any protective effect.  
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